TMPRSS4 is a type II transmembrane serine protease involved in cancer and viral infections

Biological Chemistry

Volumn 393, Issue 9, 2012, Pages 907-914

  Ohler, Anke ^a   Becker Pauly, Christoph ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Degradome; Inhibition; Protease family; Protease web; Proteolytic enzymes

Indexed keywords

HEMAGGLUTININ; SERINE PROTEINASE; TYPE II TRANSMEMBRANE SERINE PROTEASE 4; UNCLASSIFIED DRUG;

CANCER GROWTH; CELLULAR DISTRIBUTION; CONFERENCE PAPER; DIAGNOSTIC VALUE; DISEASE TRANSMISSION; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME STRUCTURE; INFLUENZA VIRUS; NEOPLASM; NONHUMAN; PATHOPHYSIOLOGY; PHYLOGENY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; VIRUS INFECTION; ZEBRA FISH;

ANIMALS; HUMANS; MEMBRANE PROTEINS; NEOPLASMS; SERINE ENDOPEPTIDASES; VIRUS DISEASES;

EID: 84869454729     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2012-0155     Document Type: Conference Paper

References (53)

1. Afar, D.E., Vivanco, I., Hubert, R.S., Kuo, J., Chen, E., Saffran, D.C., Raitano, A.B., and Jakobovits, A. (2001). Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia. Cancer Res. 61, 1686-1692.
2. Andreasen, D., Vuagniaux, G., Fowler-Jaeger, N., Hummler, E., and Rossier, B.C. (2006). Activation of epithelial sodium channels by mouse channel activating proteases (mCAP) expressed in Xenopus oocytes requires catalytic activity of mCAP3 and mCAP2 but not mCAP1. J. Am. Soc. Nephrol. 17, 968-976.
3. Antalis, T.M., Buzza, M.S., Hodge, K.M., Hooper, J.D., and Netzel- Arnett, S. (2010). The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment. Biochem. J. 428, 325-346.
4. Appel, L.F., Prout, M., Abu-Shumays, R., Hammonds, A., Garbe, J.C., Fristrom, D., and Fristrom, J. (1993). The Drosophila Stubble-stubbloid gene encodes an apparent transmembrane serine protease required for epithelial morphogenesis. Proc. Natl. Acad. Sci. USA 90, 4937-4941.
5. auf dem Keller, U. and Schilling, O. (2010). Proteomic techniques and activity-based probes for the system-wide study of proteolysis. Biochimie 92, 1705-1714.
6. Bahgat, M.M., Blazejewska, P., and Schughart, K. (2011). Inhibition of lung serine proteases in mice: a potentially new approach to control infl uenza infection. Virol. J. 8, 27.
7. Becker-Pauly, C., Bruns, B.C., Damm, O., Schütte, A., Hammouti, K., Burmester, T., and Stöcker, W. (2009). News from an ancient world: two novel astacin metalloproteases from the horseshoe crab. J. Mol. Biol. 385, 236-248.
8. Becker-Pauly, C., Barre, O., Schilling, O., Auf dem Keller, U., Ohler, A., Broder, C., Schutte, A., Kappelhoff, R., Stocker, W., and Overall, C.M. (2011). Proteomic analyses reveal an acidic prime side specifi city for the astacin metalloprotease family refl ected by physiological substrates. Mol. Cell. Proteomics 10, M111 009233.
9. Becker, C., Kruse, M.N., Slotty, K.A., Köhler, D., Harris, J.R., Rösmann, S., Sterchi, E.E., and Stöcker, W. (2003). Differences in the activation mechanism between the alpha and beta subunits of human meprin. Biol. Chem. 384, 825-831.
10. Benaud, C., Dickson, R.B., and Lin, C.Y. (2001). Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor. Eur. J. Biochem. 268, 1439-1447.
11. Bertram, S., Glowacka, I., Blazejewska, P., Soilleux, E., Allen, P., Danisch, S., Steffen, I., Choi, S.Y., Park, Y., Schneider, H., et al. (2010a). TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of infl uenza virus in Caco-2 cells. J. Virol. 84, 10016-10025.
12. Bertram, S., Glowacka, I., Steffen, I., Kuhl, A., and Pohlmann, S. (2010b). Novel insights into proteolytic cleavage of infl uenza virus hemagglutinin. Rev. Med. Virol. 20, 298-310.
13. Bork, P. and Patthy, L. (1995). The SEA module: a new extracellular domain associated with O-glycosylation. Protein Sci. 4, 1421-1425.
14. Boulware, K.T. and Daugherty, P.S. (2006). Protease specifi city determination by using cellular libraries of peptide substrates (CLiPS). Proc. Natl. Acad. Sci. USA 103, 7583-7588.
15. Cal, S., Quesada, V., Garabaya, C., and Lopez-Otin, C. (2003). Polyserase-I, a human polyprotease with the ability to generate independent serine protease domains from a single translation product. Proc. Natl. Acad. Sci. USA 100, 9185-9190.
16. Chaipan, C., Kobasa, D., Bertram, S., Glowacka, I., Steffen, I., Tsegaye, T.S., Takeda, M., Bugge, T.H., Kim, S., Park, Y., et al. (2009). Proteolytic activation of the 1918 infl uenza virus hemagglutinin. J. Virol. 83, 3200-3211.
17. Choi, S.Y., Shin, H.C., Kim, S.Y., and Park, Y.W. (2008). Role of TMPRSS4 during cancer progression. Drug News Perspect. 21, 417-423.
18. Choi, S.Y., Bertram, S., Glowacka, I., Park, Y.W., and Pohlmann, S. (2009). Type II transmembrane serine proteases in cancer and viral infections. Trends Mol. Med. 15, 303-312.
19. Friedrich, R., Fuentes-Prior, P., Ong, E., Coombs, G., Hunter, M., Oehler, R., Pierson, D., Gonzalez, R., Huber, R., Bode, W., et al. (2002). Catalytic domain structures of MT-SP1/matriptase, a matrix-degrading transmembrane serine proteinase. J. Biol. Chem. 277, 2160-2168.
20. Guipponi, M., Vuagniaux, G., Wattenhofer, M., Shibuya, K., Vazquez, M., Dougherty, L., Scamuffa, N., Guida, E., Okui, M., Rossier, C., et al. (2002). The transmembrane serine protease (TMPRSS3) mutated in deafness DFNB8/10 activates the epithelial sodium channel (ENaC) in vitro . Hum. Mol. Genet. 11, 2829-2836.
21. Guipponi, M., Antonarakis, S.E., and Scott, H.S. (2008). TMPRSS3, a type II transmembrane serine protease mutated in non-syndromic autosomal recessive deafness. Front. Biosci. 13, 1557-1567.
22. Hooper, J.D., Clements, J.A., Quigley, J.P., and Antalis, T.M. (2001). Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J. Biol. Chem. 276, 857-860.
23. Irving, P., Troxler, L., Heuer, T.S., Belvin, M., Kopczynski, C., Reichhart, J.M., Hoffmann, J.A., and Hetru, C. (2001). A genomewide analysis of immune responses in Drosophila . Proc. Natl. Acad. Sci. USA 98, 15119-15124.
24. Jia, J.B., Wang, W.Q., Sun, H.C., Liu, L., Zhu, X.D., Kong, L.Q., Chai, Z.T., Zhang, W., Zhang, J.B., Xu, H.X., et al. (2011). A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice. Invest. New Drugs 29, 861-872.
25. Jung, H., Lee, K.P., Park, S.J., Park, J.H., Jang, Y.S., Choi, S.Y., Jung, J.G., Jo, K., Park, D.Y., Yoon, J.H., et al. (2008). TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition. Oncogene 27, 2635-2647.
26. Kebebew, E., Peng, M., Reiff, E., Duh, Q.Y., Clark, O.H., and McMillan, A. (2005). ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fi ne needle aspiration biopsy. Ann. Surg. 242, 353-361; discussion 361-353.
27. Kim, S., Kang, H.Y., Nam, E.H., Choi, M.S., Zhao, X.F., Hong, C.S., Lee, J.W., Lee, J.H., and Park, Y.K. (2010). TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin α5 and its signaling pathways. Carcinogenesis 31, 597-606.
28. Kirchhofer, D., Peek, M., Lipari, M.T., Billeci, K., Fan, B., and Moran, P. (2005). Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor- 1B (HAI-1B) and HAI-2. FEBS Lett. 579, 1945-1950.
29. Kitamoto, Y., Yuan, X., Wu, Q., McCourt, D.W., and Sadler, J.E. (1994). Enterokinase, the initiator of intestinal digestion, is a mosaic protease composed of a distinctive assortment of domains. Proc. Natl. Acad. Sci. USA 91, 7588-7592.
30. Knappe, S., Wu, F., Madlansacay, M.R., and Wu, Q. (2004). Identifi cation of domain structures in the propeptide of corin essential for the processing of proatrial natriuretic peptide. J. Biol. Chem. 279, 34464-34471.
31. Kojima, K., Tsuzuki, S., Fushiki, T., and Inouye, K. (2008). Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase. J. Biol. Chem. 283, 2478-2487.
32. Larzabal, L., Nguewa, P.A., Pio, R., Blanco, D., Sanchez, B., Rodriguez, M.J., Pajares, M.J., Catena, R., Montuenga, L.M., and Calvo, A. (2011). Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology. Br. J. Cancer 105, 1608-1614.
33. Leytus, S.P., Loeb, K.R., Hagen, F.S., Kurachi, K., and Davie, E.W. (1988). A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells. Biochemistry 27, 1067-1074.
34. Li, T., Zeng, Z.C., Wang, L., Qiu, S.J., Zhou, J.W., Zhi, X.T., Yu, H.H., and Tang, Z.Y. (2011). Radiation enhances long-term metastasis potential of residual hepatocellular carcinoma in nude mice through TMPRSS4-induced epithelial-mesenchymal transition. Cancer Gene Ther. 18, 617-626.
35. Lin, C.Y., Tseng, I.C., Chou, F.P., Su, S.F., Chen, Y.W., Johnson, M.D., and Dickson, R.B. (2008). Zymogen activation, inhibition, and ectodomain shedding of matriptase. Front. Biosci. 13, 621-635.
36. List, K., Haudenschild, C.C., Szabo, R., Chen, W., Wahl, S.M., Swaim, W., Engelholm, L.H., Behrendt, N., and Bugge, T.H. (2002). Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene 21, 3765-3779.
37. Lu, D., Futterer, K., Korolev, S., Zheng, X., Tan, K., Waksman, G., and Sadler, J.E. (1999). Crystal structure of enteropeptidase light chain complexed with an analog of the trypsinogen activation peptide. J. Mol. Biol. 292, 361-373.
38. Matsushima, M., Ichinose, M., Yahagi, N., Kakei, N., Tsukada, S., Miki, K., Kurokawa, K., Tashiro, K., Shiokawa, K., Shinomiya, K., et al. (1994). Structural characterization of porcine enteropeptidase. J. Biol. Chem. 269, 19976-19982.
39. Netzel-Arnett, S., Hooper, J.D., Szabo, R., Madison, E.L., Quigley, J.P., Bugge, T.H., and Antalis, T.M. (2003). Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer. Cancer Metastasis Rev. 22, 237-258.
40. Ohler, A. and Becker-Pauly, C. (2011). Morpholino knockdown of the ubiquitously expressed transmembrane serine protease TMPRSS4a in zebrafi sh embryos exhibits severe defects in organogenesis and cell adhesion. Biol. Chem. 392, 653-664.
41. Parr, C., Sanders, A.J., Davies, G., Martin, T., Lane, J., Mason, M.D., Mansel, R.E., and Jiang, W.G. (2007). Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients. Clin. Cancer Res. 13, 3568-3576.
42. Passero, C.J., Mueller, G.M., Myerburg, M.M., Carattino, M.D., Hughey, R.P., and Kleyman, T.R. (2012). TMPRSS4-dependent activation of the epithelial sodium channel requires cleavage of the α-subunit distal to the furin cleavage site. Am. J. Physiol. Renal Physiol. 302, F1-8.
43. Ramsay, A.J., Quesada, V., Sanchez, M., Garabaya, C., Sarda, M.P., Baiget, M., Remacha, A., Velasco, G., and Lopez-Otin, C. (2009). Matriptase-2 mutations in iron-refractory iron defi ciency anemia patients provide new insights into protease activation mechanisms. Hum. Mol. Genet. 18, 3673-3683.
44. Resnick, D., Chatterton, J.E., Schwartz, K., Slayter, H., and Krieger, M. (1996). Structures of class A macrophage scavenger receptors. Electron microscopic study of fl exible, multidomain, fi brous proteins and determination of the disulfi de bond pattern of the scavenger receptor cysteine-rich domain. J. Biol. Chem. 271, 26924-26930.
45. Somoza, J.R., Ho, J.D., Luong, C., Ghate, M., Sprengeler, P.A., Mortara, K., Shrader, W.D., Sperandio, D., Chan, H., McGrath, M.E., et al. (2003). The structure of the extracellular region of human hepsin reveals a serine protease domain and a novel scavenger receptor cysteine-rich (SRCR) domain. Structure 11, 1123-1131.
46. Szabo, R. and Bugge, T.H. (2008). Type II transmembrane serine proteases in development and disease. Int. J. Biochem. Cell Biol. 40, 1297-1316.
47. Szabo, R., Wu, Q., Dickson, R.B., Netzel-Arnett, S., Antalis, T.M., and Bugge, T.H. (2003). Type II transmembrane serine proteases. Thromb. Haemostasis 90, 185-193.
48. Takeuchi, T., Harris, J.L., Huang, W., Yan, K.W., Coughlin, S.R., and Craik, C.S. (2000). Cellular localization of membrane-type serine protease 1 and identifi cation of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J. Biol. Chem. 275, 26333-26342.
49. Tseng, I.C., Chou, F.P., Su, S.F., Oberst, M., Madayiputhiya, N., Lee, M.S., Wang, J.K., Sloane, D.E., Johnson, M., and Lin, C.Y. (2008). Purifi cation from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1. Am. J. Physiol. Cell Physiol. 295, C423-431.
50. Vuagniaux, G., Vallet, V., Jaeger, N.F., Hummler, E., and Rossier, B.C. (2002). Synergistic activation of ENaC by three membranebound channel-activating serine proteases (mCAP1, mCAP2, and mCAP3) and serum- and glucocorticoid- regulated kinase (Sgk1) in Xenopus oocytes. J. Gen. Physiol. 120, 191-201.
51. Wallrapp, C., Hähnel, S., Müller-Pillasch, F., Burghardt, B., Iwamura, T., Ruthenbürger, M., Lerch, M.M., Adler, G., and Gress, T.M. (2000). A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. Cancer Res. 60, 2602-2606.
52. Wang, W., Liao, X., Fukuda, K., Knappe, S., Wu, F., Dries, D.L., Qin, J., and Wu, Q. (2008). Corin variant associated with hypertension and cardiac hypertrophy exhibits impaired zymogen activation and natriuretic peptide processing activity. Circ. Res. 103, 502-508.
53. Zhao, G., Chen, J., Deng, Y., Gao, F., Zhu, J., Feng, Z., Lv, X., and Zhao, Z. (2011). Identifi cation of NDRG1-regulated genes associated with invasive potential in cervical and ovarian cancer cells. Biochem. Biophys. Res. Commun. 408, 154-159.